| Literature DB >> 19089178 |
Cláudia de Moura Carreira1, Silvana Soléo Ferreira dos Santos, Antônio Olavo Cardoso Jorge, José Luiz Lage-Marques.
Abstract
In some situations, endodontic infections do not respond to therapeutic protocol. In these cases, it is suggested the administration of an alternative intracanal medication that presents a wide spectrum of action and has an in-depth effect on the root canal system. The purpose of this study was to assess the antimicrobial action of ciprofloxacin, metronidazole and polyethylene glycol and natrosol vehicles with different associations and concentrations. The minimum inhibitory concentration (MIC) was determined by using the agar dilution method. The culture media (Müller-Hinton agar) were prepared containing antimicrobial agents at multiple two-fold dilutions of 0.25 to 16 microg/mL, and with the vehicles at the concentrations of 50, 45, 40, 35, 30 and 25%. Twenty-three microbial strains were selected for the study. Metronidazole was not capable of eliminating any of the tested microorganisms. The association of ciprofloxacin with metronidazole resulted in a reduction of the MIC. The vehicle polyethylene glycol inhibited the growth of 100% of the tested strains, while natrosol inhibited 18% of the strains. Ciprofloxacin formulations with polyethylene glycol presented better effects than those of formulations to which metronidazole was added. It was possible to conclude that ciprofloxacin presented antimicrobial action against all tested bacterial strains, and its association with metronidazole was synergic. The vehicle polyethylene glycol showed antimicrobial effect and the ciprofloxacin/polyethylene glycol association was the most effective combination for reducing the tested bacteria and yeasts.Entities:
Year: 2007 PMID: 19089178 PMCID: PMC4327269 DOI: 10.1590/s1678-77572007000500015
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Microorganisms selected for the experiment and the source of the strains
| Microorganism (number of strains) | Strains |
|---|---|
|
| CCTU 101.001; CCTU 101.002; CCTU 101.006 |
|
| CCTU 111.004; CCTU 111.006; |
| CCTU 111.017; CCTU 111.007 | |
|
| CCTU 11.014; CCTU 11.013; ATCC 18.833 |
|
| CCTU 01.002; CCTU 01.003 |
|
| ATCC 25922; CCTU 71.001 |
|
| CCTU 51.003; CCTU 51.007; ATCC 27.853; CCTU 01.002 |
|
| ATCC 29212 |
|
| CCTU 93.002; CCTU 93.001 |
|
| ATCC 18.804; CCTU 91.001 |
Minimum inhibitory concentrations (MIC) of ciprofloxacin hydrochloride, metronidazole, polyethylene glycol and natrosol for the tested microorganisms
| Species | No. of Strains | MIC (lμg/ml) | MIC (µg/ml) | MIC (%) | MIC (%) |
|---|---|---|---|---|---|
|
| 3 | 0,5→1 | R | 30 | 35→R |
|
| 1 | 4 | R | S | R |
|
| 4 | 4 | R | S | R |
|
| 4 | S | R | S→30 | 40→R |
|
| 2 | S→1 | R | S | 40→R |
|
| 2 | S→1 | R | S | 40→R |
|
| 3 | S→1 | R | S | 40→R |
|
| 2 | R | R | 30 | 45→R |
|
| 2 | R | R | 30→40 | 45→R |
R = resistant at the highest concentration tested (16 lμg/ml or 50%); S = sensitive at the lowest concentration tested (0.25 µg/ ml or 25%); → interval of concentration of the tested products
Variation in MIC of the association of ciprofloxacin with metronidazole (0.25 to 16 µg/ml) and with polyethylene glycol (25 to 50%) and ciprofloxacin (0.25 to 16 µg/ml) with natrosol (25 to 50%) for the tested microorganisms
| Species | No. of Strains | CIM | CIM | ||
|---|---|---|---|---|---|
| Ciprofloxacin + polyethylene glycol | Ciprofloxacin + natrosol | ||||
| mg/ml | % | mg/ml | % | ||
|
| 3 | S | S | S→4 | 25→50 |
|
| 1 | S | S | 4 | 25 and 50 |
|
| 4 | S | S | 4 | 50 |
|
| 4 | S | S | 0.5→1 | 50 |
|
| 2 | S | S | 0.25 | 25 and 45 |
|
| 2 | S | S | 0.5 | 25 and 45 |
|
| 3 | S | S | 0.25 | 25 and 50 |
|
| 2 | S | 35 | 2→4 | 50 |
|
| 2 | S | 35 | 4 | 50 |
S = sensitive at the lowest concentration tested (0.25 µg/ml or 25%); → interval of concentration of the tested products
Variation in MIC of the association of metronidazole (0.25 to 16 lμg/ml) with polyethylene glycol (25 to 50%) and metronidazole (0.25 to 16 lag/ml) with natrosol (25 to 50%) for the tested microorganisms
| Species | No. of Strains | CIM | CIM | ||
|---|---|---|---|---|---|
| Metronidazole + polyethylene glycol | Metronidazole + natrosol | ||||
| mg/ml | % | mg/ml | % | ||
|
| 3 | 1 | S | 8→16 | 35→50 |
|
| 1 | 2 | S | R | R |
|
| 4 | S | S | R | R |
|
| 4 | S | S | R | R |
|
| 2 | S | S | 4 | 50→R |
|
| 2 | S→0,5 | S | 2 and 4 | 35 |
|
| 3 | S | S | 1→R | 45→R |
|
| 2 | S→16 | 30 | R | R |
|
| 2 | 0.5→8 | 30 | R | R |
R – resistant at the highest concentration tested (16 lag/ml or 50%)
S – sensitive at the lowest concentration tested (0.25 µg/ml or 25%)
→ interval of concentration of the tested products
Variation in MIC of the association of ciprofloxacin with metronidazole (0.25 to 16 mg/ml) and with polyethylene glycol (25 to 50%) or natrozol (25 to 50%) for the tested microorganisms
| Species | No. of Strains | CIM | CIM | CIM | ||
|---|---|---|---|---|---|---|
| Ciprofloxacin + Metronidazole | Ciprofloxacin + Metronidazole + Polyethylene glycol | Ciprofloxacin + Metronidazole + Natrosol | ||||
| mg/ml | mg/mL | % | mg/ml | % | ||
|
| 3 | 0.25 | S | S | 0.5 | S→45 |
|
| 1 | 2 | S | S | 4 | S→50 |
|
| 4 | 2 | S | S | 4 | S→50 |
|
| 4 | 0.25 e 1 | S | S | 0.5→1 | S→50 |
|
| 2 | 0.25 | S | S | 0.5→1 | 40→50 |
|
| 2 | 0.25 | S | S | 0.5→4 | S |
|
| 3 | 0.25 | S | S | S→4 | S→50 |
|
| 2 | R | 1→2 | 35 | 4 | S→50 |
|
| 2 | R | S→4 | S→35 | 4 | S→50 |
R = resistant at the highest concentration tested (16 lag/ml or 50%); S = sensitive at the lowest concentration tested (0.25 µg/ ml or 25%); —> interval of concentration of the tested products.